OPKO Health operates clinical laboratories and develops tests and medicines for a range of health indications. The company's BioReference Laboratories unit is one of the largest clinical lab groups in the US. The subsidiary offers routine and esoteric services including, molecular diagnostics, oncology, women's health, and genetic testing. OPKO's commercial biopharmaceutical offerings include Rayaldee for hyperparathyroidism in kidney disease patients; R&D candidates address endocrine, renal, and metabolic disorders. OPKO Health sells prescription drugs and over-the-counter products in Spain, Ireland, Chile, and Mexico, and it makes pharmaceutical ingredients in Israel. The US market accounts for most sales.
See detailed business credit reports on other businesses or your own.
See detailed profiles for insights and prospects on this company's top competitors.
Essential information for a successful call
EMPLOYEES (This Site)
EMPLOYEES (All Sites)
- ASSETS (MIL USD) 2,473
REVENUE (MIL USD)
- TICKER SYMBOL OPK
- Year Started 2007
- Incorporated 1991
- FISCAL YEAR END DEC
- SALES GROWTH % 59.15%
Similar Companies Nearby
Get in Touch with 5 Principals* and 141 Contacts
Phillip FrostChairman of the Board and Chief Executive Officer
JANE H HSIAOVice Chairman of the Board and Chief Technology Officer
STEVEN D RUBINExecutive Administration Vice-President
ADAM LOGALSenior Vice President and Chief Financial Officer and Officer and Treasurer